Novel benzimidazole derivatives as selective CB2 agonists

The preparation and evaluation of a novel class of CB2 agonists based on a benzimidazole moiety are reported. They showed binding affinities up to 1 nM towards the CB2 receptor with partial to full agonist potencies. They also demonstrated good to excellent selectivity (>1000-fold) over the CB1 receptor.

The preparation and evaluation of a novel class of CB2 agonists based on a benzimidazole scaffold are reported.Figure optionsDownload as PowerPoint slide